Inventor · disambiguated record
Mark Kayton
Also filed as: KAYTON MARK · KAYTON MARK L · KAYTON MARK LAWRENCE
6 granted patents·2 pending applications·90 citations·filing 1993–2016
81Inventor score
Files withKAYTON MARK LAWRENCE3UNIV COLUMBIA3GOVERNMENT OF THE U S A REPRES1US GOV HEALTH & HUMAN SERV1
Top patents by PatentIndex Score
8 records- 0181US6734168B2Endothelial monocyte activating polypeptide II: a mediator which activates host responseUNIV COLUMBIA·Filed 2001·Granted May 11, 2004·11 cites·3 claims
- 0280US5641867AAntibody which specifically binds to endothelial-monocyte activating polypeptide IIUNIV COLUMBIA·Filed 1993·Granted Jun 24, 1997·51 cites·4 claims
- 0368US6228837B1Endothelial monocyte activating polypeptide II: a mediator which activates host responseUNIV COLUMBIA·Filed 1994·Granted May 8, 2001·28 cites·31 claims
- 0463US9125959B1Compositions and methods for reducing or preventing medical device-related infectionsKAYTON MARK LAWRENCE·Filed 2013·Granted Sep 8, 2015·0 cites·7 claims
- 0560US2005136006A1Quantitative assay of the angiogenic and antiangiogenic activity of a test moleculeGOVERNMENT OF THE U S A REPRES·Filed 2004·Application pending·0 cites
- 0658US9339574B1Compositions and methods for reducing or preventing medical device-related infectionsKAYTON MARK LAWRENCE·Filed 2015·Granted May 17, 2016·0 cites·5 claims
- 0756US2005175980A1Quantitative assay of the angiogenic and antiangiogenic activity of a test moleculeUS GOV HEALTH & HUMAN SERV·Filed 2003·Application pending·0 cites
- 0855US9839709B1Compositions and methods for reducing or preventing medical device-related infectionsKAYTON MARK LAWRENCE·Filed 2016·Granted Dec 12, 2017·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →